[The use of a new renotropic contrast-medium in infants with special reference to magnesium metabolism (author's transl)].
Rayvist is the meglumine ioglicinate. This contrast medium is compared with Urovist in two groups of 15 infants. Electrolyte and osmolality changes in both groups are equal. In infants receiving Rayvist there were less gastro-intestinal distrubances than in those receiving Urovist. The drop of magnesium level in both groups is similar to the drop of calcium level following contrast medium injection. It is recommended to add calcium to the contrast medium in infants (1 ccm Calcium gluconicum 10% for 10 ccm contrast medium).
D002118:Calcium / Q000378:metabolism; D003287:Contrast Media / Q000009:adverse effects; D004064:Digestive System / Q000187:drug effects; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000000981:diagnostic imaging; D007483:Iothalamic Acid / Q000031:analogs & derivatives* / Q000378:metabolism; D008274:Magnesium / Q000378:metabolism*; D008536:Meglumine; D014567:Urography; D014570:Urologic Diseases / Q000000981:diagnostic imaging
D003287:Contrast Media; D007483:Iothalamic Acid; D008536:Meglumine; C019462:meglumine ioglicinate; D008274:Magnesium; D002118:Calcium
Die Anwendung eines neuen renotropen Kontrastmittels (Rayvist) im Süglingsalter unter besonderer Berücksichtigung des Magnesiumstoffwechsels.